NVCT·67080T108·US·equity·Healthcare - Biotechnology
NVCT (NUVECTIS PHARMA INC) is held by 37 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($5.9M), GEODE CAPITAL MANAGEMENT, LLC ($3M), STATE STREET CORP ($1.3M). Net institutional sentiment: Bullish.
See how NVCT's score breaks down across 4 SEC sources
Showing 1-20 of 37
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer